We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Clear all

Refine your search




95 results found


McGuireWoods LLP | USA | 7 Aug 2017

Washington Healthcare Update - Aug 7, 2017

On July 31 the House Problem Solvers Caucus, a group comprising an even number of Democrats and Republicans, released a plan to fix the ACA. The plan


Baker & Hostetler LLP | USA | 19 May 2017

Capitol Hill Healthcare Update

Legislation reauthorizing FDA user fees for prescription and generic drugs, biosimilars, and medical devices won wide bipartisan approval last week in


Baker & Hostetler LLP | USA | 18 May 2017

Health Law Update - May 18, 2017

Welcome to this week's edition of the Health Law Update. In this Issue Capitol Hill Healthcare Update Senate Panel OKs FDA User Fees Legislation


Sidley Austin LLP | USA | 1 Mar 2017

Trump Administration Will Allow Certain Affordable Care Act Noncompliant Plans to Continue Through Dec. 31, 2018

Insurers will be permitted to extend coverage under certain Affordable Care Act (ACA) noncompliant individual and small group health insurance plans


Mintz | USA | 26 Jan 2017

The Newly Updated Common Rule is Here - And On a Collision Course With the 21st Century Cures Act

On January 18th, the U.S. Department of Health and Human Services (HHS) and 15 other federal agencies issued a final rule updating regulations for


Hogan Lovells | USA | 15 Nov 2016

NIH's Clinical Trial Initiatives

Over the past few months, the National Institutes of Health (NIH) has unveiled several policies that add to the long list of regulatory obligations


Baker & Hostetler LLP | USA | 20 Oct 2016

Health Law Update - October 20, 2016

The Food and Drug Administration (FDA) and National Institutes of Health (NIH) have recently finalized or signaled intent to finalize numerous


Baker & Hostetler LLP | USA | 6 Oct 2016

Health Law Update - October 6, 2016

The U.S. Department of Health and Human Services (HHS) moved to the forefront of anti-discrimination measures when it released a final rule, titled


Hogan Lovells | USA | 19 Sep 2016

It’s Final: Expanded Registration and Results Submission Requirements for ClinicalTrials.gov

On September 16, 2016, the Department of Health and Human Services (HHS) issued a final rule that "clarifies and expands" the requirements for


Morgan Lewis | USA | 15 Aug 2016

DEA Rejects Petitions Seeking to Reschedule Marijuana

On August 12, the US Drug Enforcement Agency (DEA), despite much speculation to the contrary, published in the Federal Register its long-anticipated

Previous page 1 2 3 ...